Also, FTH1‐DOX had been shown to have a longer plasma half‐life and higher area under the concentration time curve, which might improve the retention of the drug in the systemic circulation and promote the time‐dependent accumulation of the drug in the tumor.21 The gene discussed is FTH1; the disease is neoplasm.